"GENITOURINARY CANCERS", CANCER INVESTIGATION, MARCEL DEKKER INC, US, vol. 25, no. S1, 19 September 2007 (2007-09-19), pages 17-23, XP009158701, ISSN: 0735-7907, DOI: 10.1080/07357900701571783 (B1)

ATKINS M B ET AL: "RANDOMIZED PHASE II STUDY OF MULTIPLE DOSE LEVELS OF CCI-779, A NOVEL MAMMALIAN TARGET OF RAPAMYCIN KINASE INHIBITOR, IN PATIENTS WITH ADVANCED REFRACTORY RENAL CELL CARCINOMA", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, vol. 22, no. 5, 1 March 2004 (2004-03-01), pages 909-918, XP008034968, ISSN: 0732-183X, DOI: 10.1200/JCO.2004.08.185 (B1)

BURCZYNSKI MICHAEL E ET AL: "Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 11, no. 3, 1 February 2005 (2005-02-01), pages 1181-1189, XP002392224, ISSN: 1078-0432 (B1)

DUTCHER J. P. ET AL.: "Correlation of survival with tumor histology, age, and prognostic risk group for previously untreated patients with advanced renal cell carcinoma (adv RCC) receiving temsirolimus (TEMSR) or interferon-alpha (IFN)" JOURNAL OF CLINICAL ONCOLOGY & ASCO ANNUAL MEETING PROCEEDINGS, vol. 25, no. 18S, 20 June 2007 (2007-06-20), page 5033, XP002489424 ISSN: 0732-183X (B1)

HUDES G ET AL: "A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC)", INTERNET CITATION, 20 June 2006 (2006-06-20), pages 1-2, XP002674553, ISSN: 0732-183X Retrieved from the Internet: URL:http://www.asco.org/ascov2/Meetings/Ab stracts?&vmview=abst_detail_view&confID=40 &abstractID=30421 [retrieved on 2012-04-24] (B1)

XIMING J YANG ET AL: 'A Molecular Classification of Papillary Renal Cell Carcinoma' CANCER RESEARCH, [Online] 01 July 2005, pages 5628 - 5637, XP055100585 Retrieved from the Internet: <URL:http://cancerres.aacrjournals.org/cont ent/65/13/5628.full.pdf> [retrieved on 2014-02-06] (B1)

R. J. MOTZER: 'Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non-Clear-Cell Histology' JOURNAL OF CLINICAL ONCOLOGY vol. 20, no. 9, 01 May 2002, pages 2376 - 2381, XP055100162 DOI: 10.1200/JCO.2002.11.123 ISSN: 0732-183X (B1)

SCHRADER A J ET AL: "Metastatic non-clear cell renal cell carcinoma: current therapeutic options." BJU INTERNATIONAL, [Online] vol. 101, no. 11, June 2008 (2008-06), pages 1343-1345, XP002489425 ISSN: 1464-410X [retrieved on 2008-01-30] (B1)

WO-A-2004/093854 (B1)

WO-A-2004/097052 (B1)

M. J. RATAIN: 'Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma' JOURNAL OF CLINICAL ONCOLOGY vol. 24, no. 16, 08 May 2006, pages 2505 - 2512, XP055025289 DOI: 10.1200/JCO.2005.03.6723 ISSN: 0732-183X (B1)